Ecolar
Growth of High Performance Biomaterials
Health Tech & Life Sciences
Non Active, Dec 2019 ceased to operate
Company Overview
Snapshot
Founded in August 2017, Ecolar operated with 1–10 employees. The company secured one funding round from one investor, Raz Alon, in February 2019. Ecolar ceased operations in December 2019.
Business overview
Ecolar is an Israeli biomaterials company focused on growing high-performance, premium products. The company utilizes MyCelium growing technology to produce materials that are safe, healthy, and certified sustainable. Ecolar operates within the Health Tech & Life Sciences sector, specifically in Pharma & Medical Biotechnology and Biomaterials & Tissue Engineering.
Log in to access full profile ›Company Intelligence Q&A
- What is Ecolar's primary focus?
- Ecolar specializes in the growth of high-performance biomaterials, utilizing MyCelium technology to create safe, healthy, and certified sustainable products.
- When was Ecolar founded?
- Ecolar was founded in August 2017.
- What is the operational status of Ecolar?
- Ecolar is currently non-active, having ceased operations in December 2019.
- What sector does Ecolar operate in?
- Ecolar operates within the Health Tech & Life Sciences sector, with a focus on Pharma & Medical Biotechnology and Biomaterials & Tissue Engineering.